Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-3221-2024Class II

Karl Storz - Endoskope , REF: 27293AA, Hopkins Telescope 6, Rx only, CE 0123

Karl Storz Endoscopy-America, Inc. / initiated 2024-07-23 / Open, Classified / root cause: manufacturing process

Karl Storz Endoscopy began a recall of Karl Storz - Endoskope , REF: 27293AA, Hopkins Telescope 6, Rx only, CE 0123 on . FDA classified it as Class II and gives the reason as "Various medical device product IFUs contain reprocessing modalities that have not been reviewed and/or approved for safety and efficacy by the FDA". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-3221-2024
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Karl Storz Endoscopy-America, Inc.
Product
Karl Storz - Endoskope , REF: 27293AA, Hopkins Telescope 6, Rx only, CE 0123
Product code
FGA Kit, Nephroscope
Reason for recall
Various medical device product IFUs contain reprocessing modalities that have not been reviewed and/or approved for safety and efficacy by the FDA.
Root cause tag
manufacturing process
FDA root cause
Process design
Action
On August 2, 2024, Karl Storz -Endoskope issued a "Urgent: Medical Device Correction" Notification to affected consignees via UPS Ground. Karl Storz asked consignees to take the following actions: 1. Immediately discard any previous revisions of the IFU. 2. Access the updated e-IFU at Karl Storz website 3. Pass on this Urgent Medical Device Correction to all users of the products listed and all other persons who need to be aware within your organization. 4. If you have further distributed the products listed, please identify and promptly notify those recipients of this notice and updated e-IFU. 5. Return the completed Customer Reply Form by Fax or E-Mail to the indicated contact below within 15 calendar days from the date of receipt. 6. Please report any incidents related to this issue to the manufacturer, dealer, or local representative and, if applicable, to the national competent authority, as this is important feedback. 7. (Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.)
Quantity in commerce
109 UNITS
Distribution
US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY, Puerto Rico, Guam.
Product codes and lots
All Lots/UDI: (01)04048551233795

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-3221-2024
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-3218-2024Class IIOngoingVoluntary: Firm initiated
Z-3219-2024Class IIOngoingVoluntary: Firm initiated
Z-3220-2024Class IIOngoingVoluntary: Firm initiated
Z-3221-2024Class IIOngoingVoluntary: Firm initiated
Z-3222-2024Class IIOngoingVoluntary: Firm initiated
Z-3223-2024Class IIOngoingVoluntary: Firm initiated
Z-3224-2024Class IIOngoingVoluntary: Firm initiated
Z-3225-2024Class IIOngoingVoluntary: Firm initiated